Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

NCT06386302 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

184

Enrollment

OTHER

Sponsor class

Conditions

AML
Acute Myeloid Leukemia

Interventions

DRUG: Chidamide
DRUG: Venetoclax
DRUG: azacitidine

Sponsor

Institute of Hematology & Blood Diseases Hospital, China